These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6123634)

  • 1. [2 case reports. The use of prenalterol as an antidote to massive overdosage with beta blockaders].
    Kulling P; Eleborg L; Persson H
    Lakartidningen; 1982 Feb; 79(7):518-20. PubMed ID: 6123634
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
    Kulling P
    Acta Med Scand Suppl; 1982; 659():191-9. PubMed ID: 6127889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenalterol (Hyprenan). A new cardiotonic agent].
    Pelle H; Svendsen TL; Kampmann JP
    Ugeskr Laeger; 1982 Dec; 144(49):3688-90. PubMed ID: 6133384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
    Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
    Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenoceptor blocker intoxication: epidemiological data. Prenalterol as an alternative in the treatment of cardiac dysfunction.
    Kulling P; Eleborg L; Persson H
    Hum Toxicol; 1983 Apr; 2(2):175-81. PubMed ID: 6134663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
    Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
    [No Abstract]   [Full Text] [Related]  

  • 7. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
    Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
    Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of effect of prenalterol on dialysis-associated hypotension.
    Ladefoged J
    Eur J Clin Pharmacol; 1984; 26(3):399-400. PubMed ID: 6145594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
    Andersen EB; Lindskov HO; Marving J; Boesen F; Beck-Nielsen H; Hesse B
    Dan Med Bull; 1985 Jun; 32(3):194-6. PubMed ID: 2861975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of hypotension and bradycardia with prenalterol.
    Ostergaard D; Hüttemeier P; Pedersen T
    Anaesthesia; 1984 May; 39(5):494-5. PubMed ID: 6145369
    [No Abstract]   [Full Text] [Related]  

  • 11. Inotropic effect of prenalterol in amitriptyline poisoning.
    Heath A; Mårin P; Sjöstrand I
    Intensive Care Med; 1984; 10(4):209-11. PubMed ID: 6147367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of heart failure with beta adrenoceptor agonists].
    Klein G; Wirtzfeld A; Schnelle K
    MMW Munch Med Wochenschr; 1983 Apr; 125(14):277-80. PubMed ID: 6134232
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenalterol in symptomatic sinus node dysfunction.
    Feleke E; Rydén L; Smedgård P; Westerling S
    Am Heart J; 1985 Jan; 109(1):185-7. PubMed ID: 2857060
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of beta 1-adrenoceptor stimulation and blockade studied in asthmatic airways.
    Löfdahl CG; Marlin GE; Svedmyr N
    Eur J Respir Dis Suppl; 1984; 135():151-2. PubMed ID: 6145608
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
    Coulombe D
    Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose prenalterol in beta-blockade intoxication.
    Lindvall K; Personne M; Sjögren A
    Acta Med Scand; 1985; 218(5):525-8. PubMed ID: 4091050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M
    G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
    Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
    Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental studies on therapeutic modification of sparteine poisoning].
    Strubelt O
    Arzneimittelforschung; 1982; 32(10):1287-92. PubMed ID: 6891229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenalterol as a diagnostic test in patients with pseudoischaemic T waves.
    Capucci A; Pacassoni D; Cavallini C; Magnani B
    Int J Clin Pharmacol Res; 1984; 4(3):185-94. PubMed ID: 6149196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.